Preferences for Long-Acting Pre-exposure Prophylaxis (PrEP), Daily Oral PrEP, or Condoms for HIV Prevention Among U.S. Men Who Have Sex with Men

HIV prevention method preferences were evaluated among 512 U.S. men who have sex with men (MSM; median age: 22 years). Approximately 90 % consistently preferred one option across pairwise comparisons of condoms, daily oral pre-exposure prophylaxis (PrEP), and long-acting PrEP delivered via either an...

Full description

Saved in:
Bibliographic Details
Published in:AIDS and behavior 2017-05, Vol.21 (5), p.1336-1349
Main Authors: Greene, George J., Swann, Greg, Fought, Angela J., Carballo-Diéguez, Alex, Hope, Thomas J., Kiser, Patrick F., Mustanski, Brian, D’Aquila, Richard T.
Format: Article
Language:English
Subjects:
Acquired immune deficiency syndrome
Administration, Oral
Adult
AIDS
Condoms
Condoms - utilization
Gays & lesbians
Health Psychology
Health risks
HIV
HIV Infections - prevention & control
HIV Infections - psychology
Homosexuality
Homosexuality, Male - psychology
Human immunodeficiency virus
Humans
Implants
Infectious Diseases
Injections
Male
Males
Medicine
Medicine & Public Health
Men
Original Paper
Patient Acceptance of Health Care - psychology
Pills
Pre-Exposure Prophylaxis - methods
Pre-Exposure Prophylaxis - utilization
Prevention
Privacy
Product development
Prophylaxis
Protection
Public Health
Risk
Sex
Sexual and Gender Minorities - psychology
Sexual behavior
Sexually transmitted diseases
STD
Visibility
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:HIV prevention method preferences were evaluated among 512 U.S. men who have sex with men (MSM; median age: 22 years). Approximately 90 % consistently preferred one option across pairwise comparisons of condoms, daily oral pre-exposure prophylaxis (PrEP), and long-acting PrEP delivered via either an injectable or one of two types of PrEP implants differing in visibility. Condoms were most frequently preferred (33.8 %), followed by non-visible implants (21.5 %), and oral PrEP (17.0 %); HIV risk was reported by more choosing implants. In a follow-up question comparing the four PrEP options only, daily oral pills and non-visible implants were most frequently preferred (35.5 and 34.3 %, respectively), followed by injections (25.2 %) and visible implants (4.3 %). An inductive, open-coding approach determined that convenience, duration of protection, and privacy were the most commonly cited reasons for a PrEP method choice, and associated with self-report of HIV risk. Tailoring PrEP product development to privacy and other concerns important to those at highest HIV risk may improve HIV prevention.
ISSN:1090-7165
1573-3254
DOI:10.1007/s10461-016-1565-9